Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Fluvoxamine")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 579

  • Page / 24
Export

Selection :

  • and

Therapeutic window for 5-HT reuptake inhibitorsPITCHOT, W; GONZALEZ-MORENO, A; ANSSEAU, M et al.Lancet (British edition). 1992, Vol 339, Num 8794, issn 0140-6736, p. 689Article

Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamineEL-ENANY, Nahed.Journal of AOAC International. 2007, Vol 90, Num 2, pp 376-383, issn 1060-3271, 8 p.Article

Somatic symptoms in children and adolescents with anxiety disordersGINSBURG, Golda S; RIDDLE, Mark A; DAVIES, Mark et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2006, Vol 45, Num 10, pp 1179-1187, issn 0890-8567, 9 p.Article

The onset and time course of response of negative symptoms to add-on fluvoxamine treatmentSILVER, Henry; NASSAR, Ahmed; AHARON, Nelson et al.International clinical psychopharmacology. 2003, Vol 18, Num 2, pp 87-92, issn 0268-1315, 6 p.Article

Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in ratsROCHA, Adriana; COELHO, Eduardo B; LANCHOTE, Vera L et al.Canadian journal of physiology and pharmacology. 2008, Vol 86, Num 11, pp 770-776, issn 0008-4212, 7 p.Article

Efficacy and safety of fluvoxamine in body dysmorphic disorderPHILLIPS, K. A; DWIGHT, M. M; MCELROY, S. L et al.The Journal of clinical psychiatry. 1998, Vol 59, Num 4, pp 165-171, issn 0160-6689Conference Paper

Patterns of mood variation during antidepressant treatmentBENEDETTI, F; BARBINI, B; CAMPORI, E et al.Journal of affective disorders. 1998, Vol 49, Num 2, pp 133-139, issn 0165-0327Article

An open clinical trial of fluvoxamine treatment of psychogenic excoriationARNOLD, L. M; MUTASIM, D. F; DWIGHT, M. M et al.Journal of clinical psychopharmacology. 1999, Vol 19, Num 1, pp 15-18, issn 0271-0749Article

Fluvoxamine for somatoform disorders : An open trialNOYES, R. JR; HAPPEL, R. L; MULLER, B. A et al.General hospital psychiatry. 1998, Vol 20, Num 6, pp 339-344, issn 0163-8343Article

Short-term single-blind fluvoxamine treatment of pathological gamblingHOLLANDER, E; DECARIA, C. M; MARI, E et al.The American journal of psychiatry. 1998, Vol 155, Num 12, pp 1781-1783, issn 0002-953XArticle

Perspectives on fluvoxamine therapyThe Journal of clinical psychiatry. 1997, Vol 58, issn 0160-6689, 54 p., SUP5Conference Proceedings

Rapid and sensitive bioanalytical method for measurement of fluvoxamine in human serum using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent : Application to a human pharmacokinetic studyBAHRAMI, Gholamreza; MOHAMMADI, Bahareh.Journal of chromatography. B. 2007, Vol 857, Num 2, pp 322-326, issn 1570-0232, 5 p.Article

Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatographyYASUI-FURUKORI, Norio; INOUE, Yoshimasa; KANEKO, Sunao et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 121-125, issn 0731-7085, 5 p.Article

Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population : The role of clinical, psychosocial and genetic variablesDOTOLI, Danilo; SPAGNOLO, Chiara; BONGIOMO, Fanny et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 3, pp 442-448, issn 0278-5846, 7 p.Article

A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatientsVAN DEN BROEK, Walter W; BIRKENHÄGER, Tom K; MULDER, Paul G. H et al.Psychopharmacologia. 2004, Vol 175, Num 4, pp 481-486, issn 0033-3158, 6 p.Article

Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patientsIKEDA, Manabu; SHIGENOBU, Kazue; FUKUHARA, Ryuji et al.Dementia and geriatric cognitive disorders. 2004, Vol 17, Num 3, pp 117-121, issn 1420-8008, 5 p.Article

CYP2D6 10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjectsOHARA, Koichi; TANABU, Shigeru; ISHIBASHI, Kazuhisa et al.European journal of clinical pharmacology. 2003, Vol 58, Num 10, pp 659-661, issn 0031-6970, 3 p.Article

Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patientsFUKUI, Naoki; SUZUKI, Yutaro; SAWAMURA, Kazushi et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 185-189, issn 0163-4356, 5 p.Article

Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in japanese major depressive patientsSAITO, Shinichi; TAKAHASHI, Nagahide; INADA, Toshiya et al.Neuropsychobiology. 2006, Vol 54, Num 4, pp 226-230, issn 0302-282X, 5 p.Article

Influence of gender and menopausal status on antidepressant treatment response in depressed inpatientsVERMEIDEN, M; VAN DEN BROEK, W. W; MULDER, Pgh et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 4, pp 497-502, issn 0269-8811, 6 p.Article

Dose-Dependent Effect of the CYP2D6 Genotype on the Steady-state Fluvoxamine ConcentrationWATANABE, Junzo; SUZUKI, Yutaro; FUKUI, Naoki et al.Therapeutic drug monitoring. 2008, Vol 30, Num 6, pp 705-708, issn 0163-4356, 4 p.Article

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patientsNAITO, Shingo; SATO, Kazuhiro; YOSHIDA, Keizo et al.Psychiatry and clinical neurosciences (Carlton. Print). 2007, Vol 61, Num 4, pp 421-427, issn 1323-1316, 7 p.Article

Clinical features and treatment outcome in Japanese patients with social anxiety disorder : Chart review studySHINDO, Masanobu; SHIOIRI, Toshiki; KUWABARA, Hidki et al.Psychiatry and clinical neurosciences (Carlton. Print). 2006, Vol 60, Num 4, pp 410-416, issn 1323-1316, 7 p.Article

Selective serotonin-reuptake inhibitors in the treatment of premature ejaculationMORELAND, Amanda J; MAKELA, Eugene H.The Annals of pharmacotherapy. 2005, Vol 39, Num 7-8, pp 1296-1301, issn 1060-0280, 6 p.Article

Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophreniaSILVER, Henry.International clinical psychopharmacology. 2003, Vol 18, Num 6, pp 305-313, issn 0268-1315, 9 p.Article

  • Page / 24